Results 21 to 30 of about 4,792 (191)

Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease. [PDF]

open access: yesJ Clin Med
Uremic toxins (UTs), particularly protein-bound uremic toxins (PBUTs), accumulate in chronic kidney disease (CKD) patients, causing significant health complications like uremic syndrome, cardiovascular disease, and immune dysfunction.
Sánchez-Ospina D   +6 more
europepmc   +4 more sources

A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis. [PDF]

open access: yesSci Rep, 2017
AbstractProtein-bound uremic toxins (PBUTs) are difficult to remove by conventional hemodialysis; a high degree of protein binding reduces the free fraction of toxins and decreases their diffusion across dialyzer membranes. Mechanistic understanding of PBUT kinetics can open new avenues to improve their dialytic removal.
Maheshwari V   +5 more
europepmc   +6 more sources

Assessment of Within- and Inter-Patient Variability of Uremic Toxin Concentrations in Children with CKD [PDF]

open access: yesToxins
To promote improved trial design in upcoming randomized clinical trials in childhood chronic kidney disease (CKD), insight in the within- and inter-patient variability of uremic toxins with its nutritional, treatment- and patient-related confounding ...
Evelien Snauwaert   +11 more
doaj   +7 more sources

Effect of Low Protein Diet Supplemented with Ketoanalogs on Endothelial Function and Protein-Bound Uremic Toxins in Patients with Chronic Kidney Disease [PDF]

open access: yesBiomedicines, 2023
Studies have demonstrated that a low-protein diet supplemented with ketoanalogs (KAs) could significantly retard progression of renal function in patients with chronic kidney disease (CKD) stages 3–5.
George Chang   +4 more
doaj   +2 more sources

Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Uremic toxins are emerging as important, non-traditional cardiovascular risk factors in chronic kidney disease (CKD). P-cresol has been defined as a prototype protein-bound uremic toxin.
Sophie Liabeuf   +9 more
doaj   +4 more sources

Optimization of Ibuprofen Route and Dosage to Enhance Protein-Bound Uremic Toxin Clearance During Hemodialysis [PDF]

open access: yesToxins
Protein-bound uremic toxins (PBUT), particularly indoxyl sulphate (IS) and p-cresyl sulphate (pCS), are poorly removed by conventional haemodialysis because of their strong albumin binding.
Víctor Joaquín Escudero-Saiz   +10 more
doaj   +2 more sources

The gut-kidney axis in chronic kidney disease: a vicious cycle of microbial dysbiosis and uremic toxin accumulation [PDF]

open access: yesFrontiers in Immunology
The progression of Chronic Kidney Disease (CKD) is governed by a pathogenic interplay between the host and the gut microbiota, a relationship encapsulated in the gut-kidney axis.
Ruohan Guan   +11 more
doaj   +2 more sources

Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis [PDF]

open access: yesToxins
Cardiovascular disease (CVD) frequently occurs in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. The mechanisms behind this may be related to traditional risk factors and CKD-specific factors that accelerate ...
Takuya Wakamatsu   +3 more
doaj   +2 more sources

Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate [PDF]

open access: yesToxins, 2021
Optical monitoring of spent dialysate has been used to estimate the removal of water-soluble low molecular weight as well as protein-bound uremic toxins from the blood of end stage kidney disease (ESKD) patients.
Joosep Paats   +7 more
doaj   +2 more sources

Membrane-to-Patient Optimization: Individualized Dialyzer Selection for Extracorporeal Dialysis [PDF]

open access: yesToxins
Extracorporeal dialysis for uremic toxin removal and fluid regulation relies on specialized dialyzers whose membranes differ markedly in polymer chemistry, pore architecture, adsorption capacity, surface bioactivity, and convective performance.
Mariana Murea   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy